p63 is a member of the p53 tumor suppressor family that is critical for epithelial differentiation and also has an important role in cancer progression. Currently, the molecular mechanisms governing regulation of p63 function remain largely unclear. This study identifies a unique E3 ubiquitin ligase for p63, SCF TrCP1 . SCF TrCP1 is able to bind p63␥ isoforms, with a higher affinity for the TAp63␥ isoform. Strikingly, co-expression of TAp63␥ and TrCP1 leads to the stabilization of TAp63␥. This stabilization of TAp63␥ leads to up-regulation of p21 at the mRNA and protein level by increased binding of TAp63␥ at the p21 promoter. The up-regulation of p21 causes a subsequent increase in G 1 phase cell cycle arrest. Last, SCF TrCP1 is able to ubiquitylate TAp63␥, and this ubiquitylation, as well as the increased activity of TAp63␥, is ablated with the expression of a ubiquitin-deficient mutant of TrCP1 (⌬FTrCP1). Therefore, our study reveals that SCF TrCP1 is an E3 ligase that activates p63 through ubiquitylation.